UBS Downgrades US Stock Market

The downgrade, led by UBS's Head of Global Equity Strategy Andrew Garthwaite, shifts the bank's official outlook on U.S. stocks from "Overweight" to a more cautious "Neutral" stance. This recalibration suggests that the long-standing period of American market outperformance is losing momentum. A key driver for the change is stretched valuations. On a sector-adjusted basis, U.S. price-to-earnings ratios are trading at a 35% premium compared to their international counterparts. This disparity is highlighted by year-to-date performance, where the S&P 500 has been largely flat while Japan's Nikkei 225 has surged approximately 17% and Europe's Stoxx 600 has gained around 7%. The immediate catalyst for the downgrade was a surprise surge in the January Producer Price Index (PPI), which measures wholesale inflation. The PPI rose 0.5% month-over-month, with the core reading jumping 0.8%, undermining the prevailing "soft landing" narrative and sparking fears that the Federal Reserve may delay interest rate cuts. UBS strategists also point to a structurally weaker U.S. dollar as a primary headwind, forecasting the EUR/USD exchange rate will climb to 1.22. Historically, a 10% decline in the trade-weighted dollar has led to U.S. stocks underperforming global markets by about 4%. Furthermore, policy uncertainty in Washington is adding a risk premium for investors. Frequent policy adjustments and discussions around tariffs, credit card interest rates, and limits on corporate dividends and buybacks are making it more difficult to forecast corporate earnings and expenditures. In response to these dynamics, capital is already beginning to shift. UBS has upgraded emerging market equities to "Overweight," citing cheaper valuations and supportive currency trends. Data on ETF flows confirms a broader trend of investors diversifying new allocations into overseas markets.